Selling And Administration Expenses تغییر دادن تاریخ
AbbVie USD 3.61B 273M 2023-12
Acadia Pharmaceuticals USD 111.46M 13.58M 2023-12
Acorda Therapeutics USD 21.82M 689K 2023-06
ALKERMES USD 167.95M 37.31M 2023-09
Amgen USD 1.76B 424M 2023-12
Biogen USD 608.5M 179.7M 2023-12
BioMarin Pharmaceutical USD 275.02M 51.1M 2023-12
Bluebird Bio USD 40.7M 354K 2023-09
Bristol-Myers Squibb USD 2.06B 126M 2023-12
Eli Lilly USD 1.92B 120.7M 2023-12
Gilead Sciences USD 1.61B 293M 2023-12
Heron Therapeutics USD 24.6M 11.84M 2023-09
Intra Cellular Therapies USD 104.72M 487K 2023-12
Ionis Pharmaceuticals USD 71.01M 1.06M 2023-12
J&J USD 5.81B 410M 2023-12
Malin Corporation EUR 2.2M 800K 2023-06
Marinus Pharmaceuticals USD 14.87M 854K 2023-09
Merck USD 2.75B 272M 2023-12
Minerva Neurosciences USD 2.64M 3.06K 2023-09
Nektar Therapeutics USD 21.15M 3.28M 2023-09
Neurocrine Biosciences USD 204.2M 17.6M 2023-09
Otsuka Holdings JPY 204.45B 7.72B 2023-09
Ovoca Bio EUR 2.96M 8K 2022-06
Pfizer USD 4.47B 1.27B 2023-12
Regeneron Pharmaceuticals USD 737.7M 97.2M 2023-12
Revance Therapeutics USD 67.73M 8.62M 2023-09
Vertex Pharmaceuticals USD 263.8M 1.2M 2023-09



ALKERMES فروش و مدیریت هزینه - ارزش های فعلی، داده های تاریخی، پیش بینی، آمار، نمودار و تقویم اقتصادی - Mar 2024.